Discovery Capital Management is a fund that was founded in 1999 by Rob Citrone and is one of the so-called Tiger Cub hedge funds, with Mr.
Keep Reading →
November 24 - Hedge Funds, News
One of the sectors that has benefited from the highest returns over the years is Healthcare.
Keep Reading →
November 19 - Hedge Funds, News
As the latest round of 13F filings has witnessed an increase in bullish sentiments among hedge funds.
Keep Reading →
November 18 - Hedge Funds, News
Leon Cooperman is a famous figure on the Street.
Keep Reading →
November 14 - Hedge Funds, News
Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) could lose out on a deal to acquire Botox Maker Allergan, Inc.
Keep Reading →
November 13 - News
Bill Ackman's intentions to acquire Allergan, Inc.
Keep Reading →
November 7 - Hedge Funds, News
Bill Ackman may be failing all together on his push to get Allergan to agree to a merger agreement with Valeant Pharmaceuticals Intl Inc. (NYSE:VRX).
Keep Reading →
November 7 - News
The Capitalize For Kids investors conference took place last week and featured many notorious speakers that pitched their investment ideas.
Keep Reading →
October 30 - Hedge Funds, Lists, News
Actavis plc (NYSE:ACT) is in hot water with the New York Attorney General’s office over practices they feel are manipulative of patients.
Keep Reading →
September 16 - News
40 North Management, managed by David S. Winter and David J. Millstone, recently filed its 13F with the U.S. Securities and Exchange Commission.
Keep Reading →
September 8 - Hedge Funds, News
Daniel S. Och’s OZ Management is among the investment management firms required to disclose their long equity positions once per quarter.
Keep Reading →
August 22 - Hedge Funds, News
Legendary corporate raider Carl Icahn recently filed his second quarter Form 13F with the SEC.
Keep Reading →
August 22 - Hedge Funds, News
In its latest 13F filing, GLG Partners, managed by Noam Gottesman, disclosed equity position as held at the end of June, 2014.
Keep Reading →
August 15 - Hedge Funds, News
The 4th Annual Delivering Alpha Conference will start tomorrow, July 16, in New York City, featuring various prominent figures from the finance world.
Keep Reading →
July 15 - Hedge Funds, News
Bernard Selz’s Selz Capital recently disclosed at the SEC its long equity positions as of June 30 2014.
Keep Reading →
July 14 - Hedge Funds, News
Falcon Edge Capital, a hedge fund founded –in 2012- and managed by Richard Gerson and Navroz D. Udwadia, holds an equity portfolio valued at more than $1.5 billion.
Keep Reading →
June 26 - Hedge Funds, News
North Tide Capital financial investment advisory firm headquartered in Boston, Massachusetts, founded and managed by Conan Laughlin. Before this, Mr.
Keep Reading →
June 4 - Hedge Funds, News
Dan Loeb, the manager of Third Point is one of the pioneers in activist investing.
Keep Reading →
May 23 - Hedge Funds, News
In the latest round of 13F filings, Hoplite Capital Management, led by John Lykouretzos, revealed its equity portfolio as of the end of the first quarter of the year.
Keep Reading →
May 23 - Hedge Funds, News
Over the past few days hedge funds have been filing their 13Fs for the fourth quarter of 2013, in which they disclose many of their long equity positions as of the end of December...
Keep Reading →
February 5 - Hedge Fund Analysis, Hedge Funds
In the 21st century investor’s toolkit, there are dozens of methods shareholders can use to monitor their holdings.
Keep Reading →
August 27 - News
We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors.
Keep Reading →
August 27 - Hedge Funds
Judging by the numbers, Galena Biopharma Inc (NASDAQ:GALE) isn't exactly a stock many would call great.
Keep Reading →
August 26 - News
To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time.
Keep Reading →
August 25 - News
Several weeks after the end of each quarter, hedge funds and other major investors are required to file 13Fs with the SEC to disclose many of their long equity positions as of...
Keep Reading →
August 19 - Hedge Funds
Will generic pharmaceutical makers like Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Perrigo Company (NYSE:PRGO) continue to be a value play after Obamacare kicks...
Keep Reading →
August 12 - News
Many market-watchers are scratching their heads about the pharmaceutical industry's latest blockbuster deal.
Keep Reading →
August 12 - News
A patented drug is a cash cow for drug manufacturers. There are two ways to have a patented cash generating drug on a pharmaceutical company’s pipeline.
Keep Reading →
August 5 - News
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) hardly gets the attention it deserves.
Keep Reading →
August 1 - News
AstraZeneca plc (ADR) (NYSE:AZN)’s financial results have been on a downward spiral lately, as patent expirations have led to sharp declines in sales of its leading drugs.
Keep Reading →
July 15 - News
Today's investing environment is one that forces decisions to be made and, consequently, many errors.
Keep Reading →
July 10 - News
Pharma companies have been paying off generic drug makers so that cheap generic drugs do not enter the market. In a settlement case involving AbbVie Inc (NYSE:ABBV), the U.S.
Keep Reading →
July 9 - News
Niche biotech company Warner Chilcott Plc (NASDAQ:WCRX) has been looking for an exit strategy ever since announcing strategic alternatives back in August 2012.
Keep Reading →
June 27 - News
A new Supreme Court ruling presents pharmaceutical companies with a tough choice -- stop paying generic-drug producers to withhold generic options from the market, or risk getting...
Keep Reading →
June 20 - News
When the FTC and the U.S. Supreme Court start breathing down your neck it’s not a pleasant thing, and could become very expensive for certain companies.
Keep Reading →
June 18 - News
Nothing interests a value investor more than bad news. Where there's a lack of enthusiasm, there's usually a cheap stock. Hospira, Inc.
Keep Reading →
June 14 - News
Generic-drug makers are always on the hunt for the next branded drug to take down.
Keep Reading →
June 13 - News
Searching for potential stock investments can be a daunting task.
Keep Reading →
June 13 - Hedge Funds
Five years ago, Viropharma Inc (NASDAQ:VPHM) had everything going for it.
Keep Reading →
June 12 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stirred the merger and acquisition space once again with its announcement that it is about to acquire multinational eye health firm...
Keep Reading →
June 10 - News
Generic-drug makers have considerable tailwinds, making their outperformance in the past year unsurprising.
Keep Reading →
June 6 - News
Recently, Actavis Inc (NYSE:ACT) announced that it would acquire Warner Chilcott Plc (NASDAQ:WCRX) for around $8.5 billion in total consideration.
Keep Reading →
May 30 - News
Charles Schwab Investment Management is one of the largest asset management companies, having assets worth $217 billion under management as on March 31, 2013.
Keep Reading →
May 29 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has built a unique, winning drug business by acquiring underperforming niche product franchises and incorporating them into its efficient...
Keep Reading →
May 28 - News
Currently, a majority of pharma companies are facing the issue of generic competition.
Keep Reading →
May 28 - News
Raising the minimum wage has become a hot-button issue in the U.S.
Keep Reading →
May 28 - News
Generic pharmaceutical manufacturer Actavis Inc (NYSE:ACT) made headlines after confirming that it has entered into early stage discussions with Ireland-based pharmaceutical...
Keep Reading →
May 20 - News
Generic drugmaker Actavis Inc (NYSE:ACT), itself the subject of takeover speculation, said on Monday it would buy specialty pharmaceutical company Warner Chilcott Plc (NASDAQ:...
Keep Reading →
May 20 - News
News that Montreal-based Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was in talks to merge with Parsippany, New Jersey-based Actavis Inc (NYSE:ACT) emerged barely a week after...
Keep Reading →
May 15 - News
